Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Surg.

Sec. Surgical Oncology

Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1640444

This article is part of the Research TopicKidney Cancer Awareness Month 2025: Current Progress and Future Prospects on Kidney Cancer Prevention, Diagnosis and TreatmentView all 7 articles

Incidentally detected renal leiomyosarcoma with inferior vena cava tumor thrombus: A case report with review of the literature

Provisionally accepted
  • 1Department of Urology, Deyang People's Hospital, Deyang, China
  • 2Department of Pathology, Deyang People's Hospital, Deyang, China
  • 3West China Hospital, Sichuan University, Chengdu, China

The final, formatted version of the article will be published soon.

Kidney cancer is the 14th most common cancer worldwide. On the basis of the histological characteristics of kidney cancers, most kidney cancers are renal cell carcinomas. Renal leiomyosarcoma (LMS) is extremely rare and malignant and accounts for less than 1% of all kidney cancer cases.Our study aims to gain deeper insight into the pathological characteristics and synthesized treatment of this uncommon type. Thus, we conducted a retrospective analysis of one patient who was diagnosed with renal leiomyosarcoma and underwent comprehensive treatment at the People's hospital of Deyang City.

Keywords: Renal leiomyosarcoma, case report, Inferior vena cava tumor thrombus, review, Comprehensive treatment

Received: 03 Jun 2025; Accepted: 06 Aug 2025.

Copyright: © 2025 王, Li, Liu, Lv and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Dong Lv, Department of Urology, Deyang People's Hospital, Deyang, China
Liangren Liu, West China Hospital, Sichuan University, Chengdu, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.